Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
-
Honda and Nissan expected to begin merger talks
-
'Draconian' Vietnam internet law heightens free speech fears
-
Israeli women mobilise against ultra-Orthodox military exemptions
-
Asian markets track Wall St rally as US inflation eases rate worries
-
Tens of thousands protest in Serbian capital over fatal train station accident
-
Trump vows to 'stop transgender lunacy' as a top priority
-
Daniels throws five TDs as Commanders down Eagles, Lions and Vikings win
-
'Who's next?': Misinformation and online threats after US CEO slaying
-
Only 12 trucks delivered food, water in North Gaza Governorate since October: Oxfam
-
Langers edge Tiger and son Charlie in PNC Championship playoff
-
Explosive batsman Jacobs gets New Zealand call-up for Sri Lanka series
-
Holders PSG edge through on penalties in French Cup
-
Slovak PM Fico on surprise visit to Kremlin to talk gas deliveries
-
Daniels throw five TDs as Commanders down Eagles
-
Atalanta fight back to take top spot in Serie A, Roma hit five
-
Mancini admits regrets over leaving Italy for Saudi Arabia
-
Run machine Ayub shines as Pakistan sweep South Africa
-
Slovak PM Fico on surprise visit to Kremlin
-
Gaza rescuers say Israeli strikes kill 35
-
'Incredible' Liverpool must stay focused: Slot
-
Maresca 'absolutely happy' as title-chasing Chelsea drop points in Everton draw
-
Salah happy wherever career ends after inspiring Liverpool rout
-
Three and easy as Dortmund move into Bundesliga top six
-
Liverpool hit Spurs for six, Man Utd embarrassed by Bournemouth
-
Netanyahu vows to act with 'force, determination' against Yemen's Huthis
-
Mbappe back from 'bottom' as Real Madrid down Sevilla
-
Ali hat-trick helps champions Ahly crush Belouizdad
-
France kept on tenterhooks over new government
-
Salah stars as rampant Liverpool hit Spurs for six
-
Syria's new leader says all weapons to come under 'state control'
-
'Sonic 3' zips to top of N.America box office
-
Rome's Trevi Fountain reopens to limited crowds
-
Mbappe strikes as Real Madrid down Sevilla
-
'Nervous' Man Utd humiliated by Bournemouth
-
Pope again condemns 'cruelty' of Israeli strikes on Gaza
-
Lonely this Christmas: Vendee skippers in low-key celebrations on high seas
-
Troubled Man Utd humiliated by Bournemouth
-
2 US pilots shot down over Red Sea in 'friendly fire' incident: military
-
Man Utd embarrassed by Bournemouth, Chelsea held at Everton
-
France awaits fourth government of the year
-
Germany pledges security inquest into Christmas market attack
-
Death toll in Brazil bus crash rises to 41
-
Joshua bout only fight left for beaten Fury says promoter Hearn
-
Odermatt stays hot to break Swiss World Cup wins record
-
Neville says Rashford's career at Man Utd nearing 'inevitable ending'
-
Syria's new leader vows not to negatively interfere in Lebanon
-
Germany pledges security inquest after Christmas market attack
-
Putin vows 'destruction' on Ukraine after Kazan drone attack
-
Understated Usyk seeks recognition among boxing legends
-
France awaits appointment of new government
NYSE - LSE
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its fourth quarter and fiscal year 2024 financial results after the market close on Tuesday, December 17, 2024.
The Company will host a conference call for the investment community to coincide with an update on its GMP manufacturing facility build-out on Thursday, January 9, 2025, at 4:30 p.m. ET.
Webcast and Conference Call Date & Time: Thursday, January 9 @ 4:30 p.m. ET
Dial In:
Domestic callers (toll free): 844-887-9402
International callers: 412-317-6798
Canadian callers (toll free): 866-605-3852
Live webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=3UkskFxG
A replay of the conference call will be available for 7 days following the conclusion of the call:
Replay for domestic callers (toll free): 877-344-7529, replay access code 7896562
Replay for international callers: 412-317-0088, replay access code 7896562
Replay for Canadian callers (toll free): 855-669-9658, replace access code 7896562
An accompanying slide presentation will be embedded in the webcast (live and replay) and can be accessed under the 'Company Events' section of the Applied DNA investor relations website at https://investors.adnas.com/news-events/company-events/. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; and, (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.
Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.
For additional information:
Investor Relations: Sanjay M. Hurry, 917-733-5573, [email protected]
Web: https://investors.adnas.com/
SOURCE: Applied DNA Sciences, Inc.
A.Rodriguezv--AMWN